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At least three stages in the intrathymic development of pre-T cells are demarcated by differences in the
competence to express the interleukin-2 (IL-2) gene as an acute response to stimulation. IL-2 inducibility
appears to be acquired relatively early, prior to T-cell receptor (TcR) gene rearrangement. It is then abrogated
during the stage when cells are subject to positive and negative selection, i.e., the fate determination processes
that select cells for maturation or death. IL-2 inducibility finally reappears in mature classes of thymocytes that
have undergone positive selection. To provide a basis for a molecular explanation of these developmental
transitions, we have examined the representation in different thymocyte subsets of a set of DNA-binding
proteins implicated in IL-2 gene regulation. As the DNA-binding activities of many factors are elicited only by
inductive stimuli, the cells were cultured in the presence or absence of the calcium ionophore A23187 and
phorbol ester. Our results separate these factors into four regulatory classes: (i) constitutive factors, such as
Oct-I and probably Spl, that are expressed in thymocytes at all stages; (ii) inducible factors, such as NF-KB
and complexes binding to the region of a CD28 response element, that can be activated in all thymocytes,
including those cells (CD4+ CD8+ TcRlW) that can undergo selection; (iii) inducible factors, such as NF-AT
and AP-1, that can be activated in mature (CD4+ CD8- TcRhigh) and immature (CD4- CD8- TcR-)
thymocytes alike but not in the transitional stages when the cells (CD4+ CD8+ TcROW) are subject to selection;
and (iv) a factor containing CREB, which can be activated in thymocytes of all developmental stages by culture
but does not require specific induction. These results verify that inducible transcription factors are targets of
intrathymic developmental change. They also identify NF-AT and AP-1 as factors that are particularly sensitive
to the mechanism altering thymocyte responses during the stages when thymocytes may undergo positive and
negative selection.
T-cell precursors undergo a cascade of developmental
changes in the thymic microenvironment which ultimately
endow them with the recognition specificities, signaling
mediators, and capacity for functional responses of mature T
lymphocytes (reviewed in references 10, 36, and 49). Rec-
ognition specificity is the result of the rearrangement of
T-cell receptor (TcR) genes and the cell surface expression
of their products. The TcR complex becomes effective in
triggering appropriate signaling pathways through the ex-
pression of the coreceptor molecules, CD4 and/or CD8, at
the cell surface, together with a network of cytoplasmic
protein kinases (1, 8). The acquisition of functional response
capability, however, is more complex. Mature T-cell func-
tion is exercised only in response to antigen stimulation,
through the abrupt and transient transcriptional activation of
specific response genes such as the gene encoding interleu-
kin-2 (IL-2). The competence to express IL-2 upon stimula-
tion is largely, if not exclusively, a property of T lympho-
cytes. Accordingly, one of the changes induced in precursor
cells by passage through the thymus is acquisition of IL-2
inducibility (39, 40).
Analysis of the competence to express IL-2 at various
stages of intrathymic development has revealed a series of
transitions distinct from those recognized on the basis of cell
surface phenotype and TcR expression (reviewed in refer-
ence 36). In particular, immature thymocytes before TcR
expression exhibit a form of IL-2 inducibility that seems to
be extinguished in most of their descendants, while a differ-
ent form of IL-2 inducibility is found in the minority of cells
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that go on to full maturation (9, 17, 24, 38, 39). Neither the
early inducibility nor the extinction of inducibility is well
understood in relation to the generation of mature IL-2
producers. However, these findings suggest provocative
links between responsiveness to activation signals and thy-
mocyte fate determination, as we have discussed elsewhere
(36, 39). The lymphostromal interactions responsible for the
changes in IL-2 inducibility may or may not be the same as
those that trigger quite different effects on TcR expression.
However, an advantage of using IL-2 inducibility to monitor
developmental processes is that this property is relatively
well understood at a molecular level. Thus, it is possible to
define the impact of each transition, and gain a clue as to its
mechanism, by analysis of the IL-2 gene-regulatory proteins
that it affects.
Therefore, we have taken advantage of an extensive
literature characterizing the minimal enhancer sequence of
the IL-2 gene and many of the DNA-binding proteins that
interact with it (reviewed in reference 47). Both inducible
and constitutively expressed trans-acting factors are in-
volved in initiating IL-2 gene transcription, including NF-KcB
or TcF-1 (18, 32, 42), AP-1 (20, 27), Oct-1 and other
octamer-binding proteins (21), and two uncloned factors
termed NF-AT (41) or Pu-box factor III (5, 33) and CD28RC
or the CD28 response element (CD28RE)-binding factor (11,
48). We have used electrophoretic mobility shifts to score for
the DNA-binding activities of these and other IL-2 DNA-
binding factors in thymocyte nuclear extracts after in vitro
stimulation. For those factors which do not require activa-
tion to reside in nuclei and bind DNA, these assays allow us
to score the presence of factor proteins. For those which
require specific signaling events to display DNA-binding
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activity, these assays further allow us to score cells for the
existence of the signaling pathway that controls the factor
modification. Our results demonstrate that inducible IL-2-
regulatory factors are expressed noncoordinately in T-cell
development. We further show that a full panoply of IL-2-
regulatory proteins is present in immature thymocytes.
Finally, our results show that the transitional CD4+ CD8+
TcRlOW cortical thymocytes that are the main targets of
selection are highly activatable even though functionally
incompetent, responding to stimulation with intense induc-
tion of a specific but incomplete set of IL-2 DNA-binding
activities.
MATERIALS AND METHODS
Reagents. Tetradecanoyl phorbol acetate (TPA) and the
calcium ionophore A23187 (both from Sigma) were dissolved
in dimethyl sulfoxide to the stock concentrations of 10 ,ug/ml
and 0.7 mM, respectively. Recombinant human IL-la was
purchased from Genzyme. Antisera against Fos and Jun
family proteins were kindly provided by Rodrigo Bravo.
These reagents react specifically with all known members of
the Fos and Jun families, respectively (23). Antiserum 244,
against the W39 peptide of CREB, was a generous gift from
M. R. Montminy (13). It is highly specific for recognition of
CREB (26). In addition to the published documentation of
the specificity of these antisera, we carried out controls for
specificity under the conditions of our assays. Supershifted
bands were not produced when 1 pl of a control antibody,
RL172.4 (anti-CD4 ascites fluid), was added to the reactions.
Furthermore, anti-CREB, anti-Fos, and anti-Jun did not
affect the mobility of complexes binding the NF-KB oligonu-
cleotide. We therefore consider the supershifted complexes
to be specific.
Cells. Freshly isolated thymocytes from 4- to 6-week-old
C57BL/6 mice were fractionated by complement-dependent
cytolysis or panning. To isolate immature TcR- CD4- CD8-
cells, we used complement-dependent lysis with anti-CD4
(RL172.4), anti-CD8 (3.155), and anti-CD5 (CG-15) (39), or
we used cells taken directly from the thymus of immunode-
ficient C.B-17 scid/scid (SCID) mutant mice, which are
naturally arrested at this stage (>98% TcR- CD4- CD8-)
(2). Cortical CD4+ CD8+ TcRlow thymocytes were either
enriched by adherence to peanut agglutinin-coated plates or
isolated by complement-dependent lysis with anti-H-2Kb
(28-13-33), taking advantage of their anomalously low class I
major histocompatibility complex expression (4). By either
method, the fraction contained over 92% CD4+ CD8+ cells.
Mature thymocytes were either enriched by nonadherence
to peanut agglutinin-coated plates (at 4°C) or isolated by
complement-dependent lysis (at 37°C) with anti-CD8 anti-
body. By the latter method, over 70% CD4+ CD8- and less
than 30% CD4- CD8- cells were obtained; the fraction
contained no cortical-type CD4+ CD8+ thymocytes. Flow
cytometric analysis was used routinely to confirm the phe-
notypes of the fractions. Freshly isolated SCID thymocytes
were put into culture directly, without prefractionation. All
cells were grown in RPMI 1640 supplemented with 5% fetal
bovine serum (HyClone, Logan, Utah), 2 mM L-glutamine,
50 ,uM 2-mercaptoethanol, and antibiotics, with or without
TPA (17 nM, 10 ng/ml) plus A23187 (70 to 120 nM). In some
experiments, the stimulated cells were also supplemented
with IL-1 (20 or 50 U/ml).
IL-2 bioassay. Supernatants were collected from 20-h
cultures with or without stimulation under the indicated
conditions. The IL-2 bioassay was performed as described
previously (39).
Nuclear extracts. Nuclear extracts were made from cells
cultured for 2 to 4 h according to the procedure of Stein et al.
(45). Briefly, 1 x 107 to 5 x 107 thymocytes were washed
twice with ice-cold phosphate-buffered saline and resus-
pended in 100 ,u1 of lysis buffer (10 mM N-2-hydroxyeth-
ylpiperazine-N'-2-ethanesulfonic acid [HEPES; pH 7.9], 10
mM Tris, 60 mM KCl, 1 mM EDTA, 0.5% Nonidet P-40, 1
mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride),
and then the nuclei were pelleted at 1,200 x g for 5 min at
4°C. The nuclei were washed with lysis buffer without
Nonidet P-40, then resuspended in nuclear resuspension
buffer (250 mM Tris [pH 7.8], 60 mM KCl, 1 mM dithiothre-
itol, 1 mM phenylmethylsulfonyl fluoride), and disrupted
with three cycles of freezing and thawing. After clarification
by centrifugation at 7,000 x g for 15 min, the supernatant
was collected, and the nuclear extract was stored at -80°C
until use. Protein concentrations in the extracts were deter-
mined by the Bradford assay (Bio-Rad protein assay; Bio-
Rad Laboratories, Richmond, Calif.).
Oligonucleotides. Most double-stranded oligonucleotides
were synthesized at the Microchemical Facility in our Divi-
sion of Biology. Unless specified, the sequences are found in
the 5'-flanking region of the mouse IL-2 gene (28) at dis-
tances from the cap site as shown below:
Spi consensus 5' GATCGATCGGGGCGGGGCGATC 3'
Stratagene) 3' CTAGCTAGCCCCGCCCCGCTAG 5'
NFI/CTF (4) 5' ATTTTGGCTTGAAGCCAATATG 3'
(Stratagene) 3' TAAAACCGAACTTCGGTTATAC 5'
AP-2 consensus 5' GATCGAACTGACCGCCCCGCGGCCCOGT 3'
(Stratagene) 3' CTAGCTTGACTGGCGGGGCGCCGGCA 5'
AP-1 (CREB) 5' AAMTTCAGAGAGTCATCAG 3'
(-161 to -143) 3' GGTCTCTCAGTAGTC 5'
NF-KB 5' AAGAGGGATTTCACCT 3'
(-211 to 192) 3' TTCTCCCTAAAGTGGATTTA 5'
NFAT-1 5' AAGAGGAAAATTTGTTTCATACAGAAGGCG 3'
(-289 to 260) 3' TTCTCCTTTTAAACAAAGTATGTCTTCCOCTTAA 5'
Spl 5' gatcTCTCCACCCCAAAGAGGAAAATT 3'
(-300 to -278) 3' AGAGGTGGGGTTTCTCCTTTTAActag 5'
CD28RE 5' gatcGGGGGTTTAAAGAAATTCC 3'
(-174 to 156) 3' CCCCCAAATTTCTTTAAGGctag 5'
NF-IL2A 5'gatTAAAACAT 3'
(-100 to -69) 3' A AA ATACATITGTAOVag 5'
Lowercase letters indicate bases not found in the natural
sequence. Oligonucleotides were annealed with their com-
plements and labeled by polymerization with cx-32P-labeled
deoxynucleoside triphosphates to fill in the 5' overhanging
ends.
Gel mobility shift assay. The gel shift assays were per-
formed as described previously (6), with minor modifica-
tions. Nuclear extracts (2.5 to 10 p.g of protein) were
preincubated with 0.5 to 2 p.g of poly(dI dC) at 25°C for 15
min and then incubated with 5 fmol of 32P-end-labeled
oligonucleotides (2 x 104 to 4 x 104 dpm) for another 15 min
in the final volume of 10 to 20 p.1. Reaction mixtures were
electrophoresed in 6% acrylamide gels, using 0.5x Tris-
borate-EDTA as running buffer. Gels were dried and ex-
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posed to Kodak XAR-5 film overnight at -70°C with an
intensifying screen. For competition or antibody supershift-
ing experiments, the indicated molar excess of specific
competitor DNA or 0.5 to 1 ,ul of antibody was added at the
beginning of the preincubation, before addition of the labeled
oligonucleotide. Under these conditions, the complexes
scored here (indicated by arrows or brackets in the figures)
were all sequence specific and able to be competed for by
homologous oligonucleotides.
Data analysis. To compare the representation of a given
DNA-binding protein in different extracts, as in Fig. 3
through 5, samples containing equal amounts of nuclear
protein were analyzed in parallel by electrophoretic mobility
shift assay with the same preparation of labeled oligonucle-
otide probe. The amounts of radioactivity in the shifted
complexes and, where applicable, in the unbound fraction of
the probe were determined by analysis with a Molecular
Dynamics Phosphorlmager. The levels of binding activity in
the various cell types were compared after being normalized
to the levels of Oct-1 protein determined in parallel in
aliquots of the same extracts. Results reported were all
based on at least three (usually six or more) analyses using at
least two (usually four or more) independent cell prepara-
tions.
The introduction of antibodies to identify complexes con-
taining CREB, Jun, and Fos significantly perturbs quantita-
tion. In our hands, the antibody against CREB appears to
enhance the DNA-binding affinity of the complexes that it
reacts with, so that the total amount of complex (shifted plus
supershifted by reaction with antibody) appears greater than
the amount of complex formed in the absence of antibody.
Conversely, the antibodies against Jun and Fos individually
reduce the DNA-binding affinity of the complexes that they
react with and appear to reduce the overall amount of
complex formed when they are used together in supershift-
ing experiments (data not shown). We have therefore esti-
mated the relative amounts of AP-1 (Fos/Jun) complexes
only from the level of complex formed that is not super-
shifted by anti-CREB.
RESULTS
Nuclear extracts from cells in defined stages of T-cell
development. To define the IL-2-regulatory proteins present
at various stages of thymocyte development, we prepared
nuclear extracts from isolated subsets of thymocytes repre-
senting the immature (CD4- CD8- TcR-), transitional (cor-
tical CD4+ CD8+ TcROW), and mature helper-type (CD4+
CD8- TcRhigh) stages of development. The nuclear extracts
from these populations were then used in electrophoretic
mobility shift assays to detect factors capable of binding to
any of a panel of double-stranded synthetic oligodeoxynu-
cleotide probes derived from the murine IL-2 5' flanking
sequence. The sequences of these probes are listed in
Materials and Methods. Previous reports and our own pre-
liminary studies had indicated that the appearance of certain
critical binding activities depended on cellular activation.
Therefore, we prepared nuclear extracts from thymocyte
subsets that were cultured for 2 to 4 h with or without
stimulation with the phorbol ester TPA (17 nM) plus the
Ca2+ ionophore A23187 (70 to 120 nM). These stimuli mimic
the second messengers induced by TcR ligands but do not
require the presence of the TcR complex and therefore allow
cells from a broad range of developmental stages to be
assayed for responsiveness.
Each population of cells analyzed was prepared by two
TABLE 1. IL-2 inducibility in thymocyte subpopulations
IL-2 activity (U/mV/S x 106 cells)6
Cell populationa
Exp 1 Exp 2 Exp 3
Total thymus
Unstim. <4C
Stim. 52 33
Stim. + IL-1 104
CD4+ CD8-d
Unstim.
Stim. 323
CD4+ CD8+e
Unstim. <4
Stim. 3.5
TcR- CD4- CD8-f
Unstim. <4
Stim. <4
Stim. + IL-1 355
SCID
Unstim. <4
Stim. 99 37
Stim. + IL-1 1,581 848
a Cells were prepared as described in the text and cultured as indicated for
20 h. Unstim., unstimulated; Stim., in the presence of 100 nM A23187 and 17
nM TPA; Stim. + IL-1, as for Stim. plus IL-2 at 20 U/ml for experiment 1 and
50 U/ml for experiment 2.
b Measured by bioassay on CTLL-2 cells. Units are defined in a given
experiment as described in reference 39. Where no value is shown, that
sample was not included in a particular experiment. Results from experiments
with 3 independent cell preparations, representative of over 10 independent
experiments, are given (see also references 24 and 38 to 40).
c Undetectable.
d Prepared by cytolysis with anti-CD8. This fraction also contained -30%
CD4- CD8- cells.
e Prepared by cytolysis with anti-H-2K". This fraction consisted of 92%
CD4+ CD8+ cells with <5% each CD4+ CD8-, CD4- CD8+, and CD4-
CD8- cells.
f Prepared from normal mice.
different methods to control for any perturbations in cell
physiology that might be caused by a particular method of
fractionation (see Materials and Methods). For any given
thymocyte subset, the different methods of isolation in fact
yielded essentially indistinguishable profiles of DNA-binding
proteins. Thus, the differences between fractions discussed
below reflect intrinsic cellular characteristics and not simply
artifacts of the isolation procedure.
The immature CD4- CD8- TcR- cells, cortical-type
CD4+ CD8+ TcRlOw cells, and mature CD4+ CD8- TCRhigh
cells differ significantly in the ability to express IL-2 upon
induction (Table 1). In all cases, IL-2 protein secretion
(Table 1) agrees well with IL-2 RNA expression, as mea-
sured by in situ hybridization and by quantitative RNase
protection assays, as described elsewhere (25, 39, 40). The
CD4+ CD8- TcR+ cells (initially -10% of total thymus) are
about 10-fold enriched for the ability to express IL-2 relative
to unfractionated thymocytes, whereas cells in the CD4+
CD8+ TcRIW fraction (initially 80% of total thymus) are at
least 20-fold depleted of this ability. The immature cells from
the SCID thymus produce modest amounts of IL-2 under
normal stimulation conditions and very high levels if IL-1 is
added. In this intense IL-1-dependent response, they resem-
ble normal immature thymocytes, which have the capacity
to express high levels of IL-2 but do so only when IL-1 is
present (Table 1). By contrast, addition of IL-1 does not
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FIG. 1. NF-IL2A (O't-1) binding activity in thymocytes. The
NF-IL2A oligonucleotide (-100 to -69) was used as a probe to test
the binding activity in nuclear extracts from unfractionated thymo-
cytes (total thymocytes [T.T.]; lanes 1 and 2), SCID thymocytes
(lanes 3 and 4), CD4+ CD8+ TcROW cortical thymocytes (double
positive [DP]; lanes 5 and 6), and a population enriched for mature
CD4+ CD8- TcRhigh thymocytes (CD4; lanes 7 and 8). The cells
were cultured in the absence (-) or presence (+) of A23187 plus
TPA (Stim.) for 4 h prior to lysis. Aliquots estimated to represent
equal amounts of nuclear protein from each sample were compared;
in fact, the sample in lane 2 contained less protein than did the other
samples. The electrophoretic mobility shift assay was performed as
described in Materials and Methods.
a T.T. SCID DP CD4
,,F iStim. - + - +-+-
b
Competitor
Molar Excess
reveal any cryptic IL-2 inducibility in the CD4+ CD8+
TcRlow cells (38; data not shown). These results agree well
with previously published data (16, 24, 34, 38, 39) indicating
that these fractions are functionally and phenotypically
consistent.
DNA-binding factors present in developmental thymocyte
subsets. The results of the electrophoretic mobility shift
experiments revealed that the factors capable of binding to
IL-2 gene flanking sequences can be divided into four classes
on the basis of their developmental regulation.
(i) Constitutive activities. As shown in Fig. 1, all thymocyte
fractions possess a nuclear protein with binding activity for
the NF-IL2A element (-100 to -69), with or without
induction by TPA plus A23187. Its mobility compared with
those of the NFIL-2A-binding proteins in ELA.E1 cells
suggests that this protein is Oct-1 (data not shown). In over
10 independent experiments, there was no consistent differ-
ence between fractions or between stimulated and unstimu-
lated samples in the amount of this binding factor relative to
total nuclear protein.
Another factor that appeared to be expressed constitu-
tively was one that binds to the oligonucleotide containing a
sequence upstream of the NF-AT site, namely, the region
from -300 to -278 (Fig. 2a). Despite the lack of any
conventional Spl sites in the IL-2-regulatory region (29), the
-300/-278 oligonucleotide includes a sequence, CCAC
CCC, which is similar to a reported variant Spl-binding site
(44). In fact, the -300/-278-binding factor binds with much
higher affinity to a consensus Spl oligonucleotide than to the
-300/-278 oligonucleotide itself, as demonstrated by the
>10-fold difference between the molar efficiencies of these
oligonucleotides as competitors (Fig. 2b). Binding of the
thymocyte factor could not be significantly competed for by
a
-300/-278 Q) SP-1 0) NF1
0 80
0
60
0
IZz 40 1 320 z' 35 70 140280 z' 35 70 140 280
"Sp-J..
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FIG. 2. Analysis of a constitutive DNA-binding activity in thymocytes that interacts specifically with the -300/-278 sequence. (a) Protein
binding study. Nuclear extracts from samples of thymocytes that were cultured with (+) or without (-) stimulation were analyzed as for Fig.
1 to measure proteins binding to the -300/-278 oligonucleotide. Symbols and abbreviations are as defined in the legend to Fig. 1. The arrow
indicates the prominent specific complex that may correspond to Spl. (b) Results of a competition experiment suggesting that the major
complex formed with the -300/-278 oligonucleotide may be closely related to Spl. The indicated competitor oligonucleotides were added
to an unfractionated thymocyte extract in the molar excesses over the labeled probe that are indicated above the lanes. The relatively poor
self-competition by the -300/-278 oligonucleotide and the strong competition by the consensus Spl oligonucleotide indicate that the factor
binds to the -300/-278 site with relatively low affinity. No competition is observed with the unrelated NF1 oligonucleotide.
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FIG. 3. Comparison of inducible NF-KB site-binding activity in
different thymocyte subsets. Samples of the extracts analyzed in
Fig. 1 and 2 were incubated with an oligonucleotide spanning from
mouse IL-2 positions -211 to -192 to test for specific NF-KB
site-binding activity. The specific inducible NF-KB-binding complex
is indicated by the arrow. Abbreviations are as defined in the legend
to Fig. 1.
a consensus AP-2 oligonucleotide in excess (data not
shown), even though in some cases AP-2 is reported to bind
similar sequences (35). Thus, it is likely that Spl or a relative
of Spl may bind to this site. Our in vivo genomic footprinting
studies confirm that this candidate Spl site does become
occupied as part of a coordinated protein-DNA binding
complex during IL-2 induction (12).
(ii) Inducible factors correlated with developmental progres-
sioa. The factors binding to the NF-KB site (-211 to -192)
and to the region (-174 to -156) associated with a proposed
CD28RE differ from the previous two in that their DNA-
binding activities are highly dependent on induction. Both
their induction dependence and their relative inducibilities in
different thymocyte subsets define the factors that bind the
NF-KB (Fig. 3) and CD28RE (Fig. 4) sites as members of a
separate regulatory class.
Inducible factors binding the NF-KcB and CD28RE oligo-
nucleotides were observed in all thymocyte subsets. In the
case of the NF-KB site, two well-defined complexes were
seen, possibly representing the p65-pSO and p5O-pSO forms of
this transcription factor. As we have noted previously for the
model IL-2-inducible cell line EL4.E1 (28), the appearance
of the upper complex (putative p65-pSO form or T-cell-
specific TCF; indicated by the arrow in Fig. 3) was more
stringently induction dependent. We provisionally refer to
this factor as NF-KB in the text that follows. The factors
binding the CD28RE oligonucleotide formed multiple re-
tarded complexes that were distinctively enhanced upon
induction (bracket in Fig. 4). The specific type of complex
reported to be induced in human Jurkat cells by CD28
engagement (11) may correspond to one of these bands but
1 2 3 4 5 6 7 8
FIG. 4. Comparison of CD28RE-binding activity in different
thymocyte subsets. The oligonucleotide spanning from IL-2 posi-
tions -174 to -156 was used in a binding assay with the panel of
extracts analyzed in Fig. 1 through 3. The bracketed bands indicate
inducible specific complexes. The complexity of this pattern, rela-
tive to that reported previously (11), may be due to the inclusion in
our CD28RE oligonucleotide of five G residues that are omitted in
the oligonucleotide used by Fraser et al. (11). Abbreviations are as
defined in the legend to Fig. 1.
was not definitively identified in this study (see the legend to
Fig. 4). However, in the aggregate, these complexes be-
haved as a cluster of inducible DNA-binding proteins whose
activation, like that of NF-KB, could be seen as the outcome
of a successful signal transduction cascade.
Although the CD4+ CD8+ TcRIw cortical thymocytes
could make no IL-2, we found that they activate both the
NF-KB upper complex and CD28RE-binding factors to levels
at least as high, relative to Oct-1 or total nuclear protein
levels, as in most preparations of SCID thymocytes (Fig. 3
and 4; compare lanes 4 and 6). The lower complex, which
may represent a p5O-p5O homodimer, has been associated
with repression of IL-2 expression (22). Although it appears
to be expressed in a high ratio relative to the upper complex
in the CD4' CD8+ cells illustrated in Fig. 3 (lane 6), more
commonly the ratio of lower to upper complex in these cells
was the same as in the other subsets of thymocytes.
(iii) Inducible factors correlated with IL-2 inducibility.
Factors capable of binding to the NF-AT and AP-1p sites
defined a third class of factors. The binding activities asso-
ciated with these factors were highly induction dependent,
like the factors in the second group. However, in contrast to
the second group, the NF-AT and AP-1 (see below) factors
appeared to be inducible mainly or exclusively in cells
competent to express IL-2, and in both mature cells and
immature thymocytes alike.
Figure 5 shows the results of assaying thymocyte extracts
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FIG. 5. Comparison of NF-AT-binding activity in different thy-
mocyte fractions. The figure shows a typical result when the
oligonucleotide from mouse IL-2 positions -289 to -260 was used
in the binding assay with the panel of extracts used for Fig. 1
through 4. The inducible NF-AT complex is indicated by an arrow.
Abbreviations are as defined in the legend to Fig. 1.
for NF-AT activity. NF-AT binding was highly inducible in
mature CD4' cells but low or undetectable in unfractionated
and CD4+ CD8+ cortical thymocytes (Fig. 5, lanes 2, 6, and
8). These results are in full agreement with the report by
Riegel et al. (34). The inducibility of NF-AT-binding activity
was not restricted to cells in the final stage of T-cell
differentiation and maturation, however. SCID thymocytes
(as well as CD5lOW CD4- CD8- TcR- thymocytes isolated
from normal mice; data not shown) were able to mobilize
NF-AT-binding activity to levels quite comparable with
those of mature CD4+ CD8- Tchigg cells. A comparative
titration of nuclear extracts from stimulated CD5loW CD4-
CD8- TcR- immature cells from normal mice and stimu-
lated CD4+ CD8+ TcRloW cortical cells showed that the
immature cells contained at least 10 times more NF-AT
DNA-binding activity than do the cortical cells (data not
shown). Thus, NF-AT inducibility appears to be acquired at
an early developmental stage.
(iv) Developmentally distinct factors binding to the AP-1
site. Our results indicate that the major AP-1 site at -161 to
-143 in the IL-2 5' flanking region (AP-lp) can be engaged
by at least two differentially regulated factors, one conven-
tionally inducible factor consisting entirely of Fos and Jun
family members (AP-1 complex) and one which includes at
least one CREB subunit (CREB complex). The two com-
plexes were similar in electrophoretic mobility and could be
resolved only by use of antibodies.
All thymocyte subsets contained factors capable of bind-
ing to the putative AP-1 site, and surprisingly, most did so
with or without in vitro stimulation (Fig. 6a). In total
thymocytes overall and in isolated CD4+ CD8+ TcRloW cells,
essentially all of the AP-lp site-binding activity was attrib-
utable to the CREB complex, whether or not the cells were
stimulated (Fig. 6b, lane 2; Fig. 6c, lanes 1, 2, 7, and 8).
CREB complexes were present in unstimulated cells of all
subsets (Fig. 6c, lanes 1, 3, 7, and 9). Levels of the CREB
complex appeared to be increased by exposure of the
thymocytes to culture at 37°C (data not shown) but were not
enhanced by TPA plus A23187. In CD4+ CD8- TcRhigh and
SCID thymocytes specifically, however, activation with
TPA plus A23187 led to strong induction of an AP-1 complex
(Fig. 6c, lanes 3, 4, 9, and 10). Thus, we conclude that (i) all
thymocytes can activate a leucine zipper family factor in-
cluding at least one CREB subunit simply in response to
stimuli such as a temperature shift and (ii) immature and
mature thymocyte subsets alike can activate a canonical
AP-1 factor in response to Ca2+ ionophore and protein
kinase C stimulation, but (iii) cortical CD4+ CD8+ TcRlOW
thymocytes are specifically disabled in their activation of the
inducible AP-1 factor despite their ability to activate other
factors such as the CD28RE-binding complexes and NF-KB.
DISCUSSION
Summary of developmental changes in IL-2 DNA-binding
factors. The pattern of inducibility of the DNA-binding
proteins studied here is summarized qualitatively in Fig. 7.
As a framework for the following discussion, the data are
presented as a hypothetical developmental progression, in
which the average cell types in each of the fractions studied
here are assumed to be linked in a precursor-product con-
tinuum. The discontinuities in the inducibility of AP-1 (Fos/
Jun) and NF-AT, both at the immature-to-cortical transition
and, presumably, at the cortical-to-mature transition (see
below) contrast sharply with the gradual, monotonic in-
creases in the inducibility of NF-KB and at least the majority
of the complexes that bind to the CD28RE oligonucleotide.
Each thymocyte subset has its own characteristic profile of
these factors. The combinatorial requirement for these fac-
tors in assembling IL-2 transcription complexes accounts for
the ability of immature thymocytes and the inability of their
cortical thymocyte descendants to express the IL-2 genes.
The most interesting aspect of these results, however, is the
light that they shed on the kinds of physiological changes
imposed on developing thymocytes during intrathymic pro-
cessing.
Reverse maturation of function in the immature-to-cortical
thymocyte transition. The results presented here show that
cells in the immature population can already deploy a set of
transcription factors that includes all those known to be
needed f,r IL-2 expression in mature cells. Even NF-AT,
initially described as a mature T-cell-specific factor, is al-
ready highly inducible in these cells. Any developmental
changes needed to turn on NF-AT expression must therefore
already have occurred at this stage, before TcR gene rear-
rangement. Furthermore, the signaling pathways needed to
activate NF-AT and other regulatory factors already appear
to be effectively indistinguishable in immature cells from
those in mature T cells. Both normal CD4- CD8- TcR-
populations (data not shown) and SCID thymocytes could
activate NF-AT, the AP-1 complex, and other regulatoxy
factors comparably to mature cells in response to A23187
plus TPA. Surprisingly, costimulation with IL-1 did not
appear to be required for induction of any of these activities.
The only difference in DNA-binding protein activation ob-
served in the immature cell samples (normal or SCID) when
IL-1 was added was a modest enhancement of the induction
of the NF-KB binding activity (data not shown). The basis for
the strong observed effect of IL-1 on IL-2 RNA and protein
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FIG. 6. AP-1/CREB proteins of thymocytes. (a) Comparison of AP-M site-binding activity in different thymocyte fractions. Nuclear
extracts from the indicated thymocyte samples were analyzed for compfex formation with the AP-1 oligonucleotide. Abbreviations for
thymocyte samples and culture conditions are as given in the legend to Fig. 1. (b) Reactivity of AP-1p site-binding factors in cortical
thymocytes with different antibodies. An extract from stimulated CD4+ CD8+ TcRIW thymocytes was used for electrophoretic mobility shift
assays with the AP-lp oligonucleotide, with the following antibodies (Ab) added: lane 1, none; lane 2, anti-CREB; lane 3, anti-Fos and anti-Jun
family; lane 4, all three antibodies. Anti-CREB shifts a much larger fraction of the initial, unperturbed binding activity than does anti-Jun plus
anti-Fos. The material reactive with anti-CREB defines the CREB complex. (c) Differential expression in thymocyte subsets of Fos/Jun and
CREB complexes with binding activity for the AP-lp site. Extracts from the thymocyte samples shown in panel a were analyzed for binding
to the AP-lp oligonucleotide in the presence of the following antibodies: anti-CREB (C), anti-Fos family plus anti-Jun family (FJ), and a
cocktail of all three antibodies (FJC). As CREB-like factors are present in all samples, all C lanes contain supershifted (antibody-bound)
complexes. The Fos/Jun or AP-1 complex referred to in the text is the material in the lanes treated with anti-CREB that remains in the
antibody-unbound position. Lanes 6 and 12 verify that all this material is in fact reactive with anti-Jun and/or anti-Fos.
expression (9, 17, 39) must therefore reside elsewhere and
remains under investigation. However, the results presented
here clearly show that the molecular prerequisites for IL-2
producer function that we can score have already been
achieved through extremely early events in T-cell develop-
ment, in a process completely independent of T-cell recog-
nition specificity.
In this context, the transition to CD4+ CD8+ TcRlow
cortical thymocyte status is confirmed as a loss of response
function. However, the loss is surprisingly specific. Previous
work had shown that murine CD4+ CD8+ TcRlW thymo-
cytes fail to express known response genes, like the IL-2 and
IL-2 receptor alpha-chain genes, even when the TcR is
bypassed with strong pharmacological stimuli (4, 8, 9, 16,
24). A priori, the cells might have been found to lack basic
molecular transducers of signals such as calmodulin or
appropriate isoforms of protein kinase C. Instead, the results
described here show that these cells are capable of strong
though selective transcription factor activation. For exam-
ple, the inducibility of NF-KB in these cells makes it likely
that a fully operational protein kinase C-dependent pathway
is present. Thus, the dissociation of one ubiquitous phorbol
ester-inducible response from another, in the selective loss
of AP-1 induction while NF-KB induction is preserved,
implies a precise, factor-specific mechanism rather than a
cataclysmic, global change in cell physiology. There are two
implications of these results. First, the reverse maturation
process in which AP-1 and NF-AT inducibility are lost
defines a novel transition in thymocyte development. Its
possible timing and significance are discussed further below.
Second, the cells in this functionally incompetent population
remain highly responsive, with an ability, in principle, to
integrate signals from protein kinase C, cyclic AMP/protein
kinase A (50), and possibly also CD28 (14, 46) for transcrip-
tion factor mobilization. Their potential to carry out effi-
cient, if specialized, patterns of gene expression is further
supported by our recent evidence that they can serve as
preferential targets for transient expression of certain exog-
enous DNAs in transfection experiments (30). Thus, the
cortical thymocytes need not be beyond rescue; in fact, the
repertoire of inducible transcription factors that they pre-
serve might participate in the poorly understood processes
of positive and negative selection.
Selection and the selectable state. A most interesting pos-
sibility raised by these results is that changes in NF-AT and
AP-1 inducibility may contribute to the mechanisms that (i)
make thymocytes subject to selection and (ii) transform
them into mature thymocytes via positive selection. Figure 7
indicates a possible temporal correlation between these
important developmental transitions and the discontinuities
in the use of NF-AT and AP-1. At present, this hypothesis is
speculative, because it is not yet known whether the "typi-
cal" subset members depicted in Fig. 7 are truly related in a
precursor-product continuum. However, the striking simi-
CD4C
- t+t+
C C FJi FJO
b1
MOL. CELL. BIOL.
..ft
DEVELOPMENTAL CONTROL OF IL-2 TRANSCRIPTION FACTORS
TcRWCD4&j8-1 *
.5:
0
co
0-
C)
coRr
|TcROWCD4+8+ * TcRhi9'CD4+8j1
Qt( i)
SSP1"?
(ii)
( iii)
AP-1
NF-AT
-----------
_CREB_. (iI})
Rearrangement
of TcR genes Positive selection
Selectable
FIG. 7. IL-2 DNA-binding factors in thymocytes: a proposed developmental progression. This summary figure juxtaposes the results from
Fig. 1 through 6 on the abundance of various IL-2 DNA-binding factors in three broad stages of thymocyte differentiation. The data are
arranged along a horizontal axis that represents the differentiative progress of thymocytes toward maturity, with the key events that mark
transitions and states of interest indicated. While the characteristics of the three stages are established by our results, the proposed
connections between them are hypothetical, as discussed in the text. The vertical axis represents relative levels of DNA-binding activities of
various factors, expressed on an arbitrary scale, with the results for different classes of factors offset. As the true copy numbers of different
factors are not known, the values along the vertical axis in this figure cannot be used to compare one factor with another. (i), (ii), (iii), and
(iv) refer to the four regulatory classes of factors distinguished in the text. * , true constitutive factors. - - -, CREB, the binding activity
of which is increased by culture but is not dependent on Ca2+/protein kinase C activation; , factors whose DNA-binding activity is
detectable only after Ca2+/protein kinase C activation.
larities between the IL-2 DNA-binding activities available in
immature and mature thymocytes suggest two possible kinds
of linkages between transcription factor regulation and thy-
mocyte fate determination. One, an alternative to the
scheme shown in Fig. 7, is that the downregulation of
NF-AT and AP-1 may occur only in cells that have failed
positive selection and are committed to die. In this case,
cortical thymocytes that remain susceptible to positive se-
lection could be identified as a subset specifically protected
from NF-AT and AP-1 downregulation, bypassing the typi-
cal cortical cell state. The other possibility, illustrated in Fig.
7, is that a relatively simple, reversible molecular switch
may shut off AP-1 and NF-AT inducibility prior to any
selection and restore it as a consequence of selection. In this
case, the mechanism controlling NF-AT and AP-1 inducibil-
ity would define one of the molecular targets of the positive
selection process. The choice between these alternative
interpretations depends on the precise timing of NF-AT and
AP-1 downregulation relative to TcR gene rearrangement
and surface expression. As of this writing, the possibility
depicted in Fig. 7 is favored by two kinds of evidence. We
and others have already shown that thymocytes lose a
variety of inducible gene expression responses at a stage
well before their acquisition of a selectable TcR (3, 9, 37, 51).
Also, our own preliminary results (7) indicate that NF-AT
and AP-1 inducibility has already been lost by cortical
thymocytes that are still actively in cycle, a population that
clearly includes cells with full precursor activity that may yet
be positively selected (15, 19, 31, 43). Thus, no evidence yet
available suggests loss of activatability as a late event. If
further investigation confirms the early timing of NF-AT and
AP-1 downregulation, then this process must be reversible,
as a direct or indirect consequence of positive selection.
Work to define the biochemical basis of the changes in AP-1
and NF-AT availability is now under way.
In summary, the data from this study identify NF-AT and
the AP-1 complex described here as potentially valuable
probes to define the mechanisms regulating the varying
responses of thymocytes to activation in the course of their
development. A full understanding of their changes in activ-
ity must await the cloning of the genes encoding NF-AT
components and the identification of AP-1 family members
that actually participate in IL-2 regulatory complexes. How-
ever, the inducibility of these factors is at least correlated
with the abrupt changes in cellular responses to signaling
that define both onset of and rescue from the selectable
state. Furthermore, their pleiotropic roles in response gene
regulation can explain the functional effects of the regulatory
changes. Whether or not their function is also implicated in
the fate determination events per se, they provide likely
molecular targets of the switch mechanism that transforms
cell physiology to convert simple activation signals into the
arbiters of irreversible developmental choice.
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